Loading company…
NINAMED develops wearable neuromodulation devices for pelvic health disorders.
Melbourne-based NINAMED develops wearable neuromodulation technology for pelvic health conditions, including overactive bladder. Its NiNA product targets the Saphenous nerve and is designed as a noninvasive, drug-free treatment. In May 2026, the company raised USD 13.75 million in Series A funding led by Sprim Ventures, with participation from SV Health Investors. The funding will support device development, regulatory approval, and operations.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in